Clinical Trials Browser

Phase 2 × Eye Neoplasms × MART-1 Antigen × Clear all

NCT00020475 2024-03-04

Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye

Phase 2 Completed

Uveal Melanoma, Eye Neoplasms, Neoplasms